This website uses cookies. Cookies help us to provide our services. By using our services, you consent to our use of cookies. Your data is safe with us. We do not pass on your analysis or contact data to third parties! Further information can be found in the data protection declaration.
BioNTech: Covid-19-premonition, -pre-financing and -crisis profit
17.05.2022
Subtitle "Afrikaans" was produced by machine.Subtitle "አማርኛ" was produced by machine.Subtitle "العربية " was produced by machine.Subtitle "Ārāmāyâ" was produced by machine.Subtitle "azərbaycan dili " was produced by machine.Subtitle "беларуская мова " was produced by machine.Подзаглавието "България" е създадено от машина.Subtitle "বাংলা " was produced by machine.Subtitle "བོད་ཡིག" was produced by machine.Subtitle "босански" was produced by machine.Subtitle "català" was produced by machine.Subtitle "Cebuano" was produced by machine.Subtitle "ગુજરાતી" was produced by machine.Subtitle "corsu" was produced by machine.Podtitul "Čeština" byl vytvořen automaticky.Subtitle "Cymraeg" was produced by machine.Subtitle "Dansk" was produced by machine.Untertitel "Deutsch" wurde maschinell erzeugt.Subtitle "Untertitel" was produced by machine.Subtitle "Ελληνικά" was produced by machine.Subtitle "English" was produced by machine.Subtitle "Esperanto" was produced by machine.El subtítulo "Español" se generó automáticamente.Subtitle "Eesti" was produced by machine.Subtitle "euskara" was produced by machine.Subtitle "فارسی" was produced by machine.Subtitle "Suomi" was produced by machine.Le sous-titre "Français" a été généré automatiquement.Subtitle "Frysk" was produced by machine.Subtitle "Gaeilge" was produced by machine.Subtitle "Gàidhlig" was produced by machine.Subtitle "Galego" was produced by machine.Subtitle "Schwizerdütsch" was produced by machine.Subtitle "هَوُسَ" was produced by machine.Subtitle "Ōlelo Hawaiʻi" was produced by machine.Subtitle "עברית" was produced by machine.Subtitle "हिन्दी" was produced by machine.Subtitle "Mẹo" was produced by machine.Subtitle "Hrvatski" was produced by machine.Subtitle "Kreyòl ayisyen " was produced by machine.Subtitle "Magyar" was produced by machine.Subtitle "Հայերեն" was produced by machine.Subtitle "Bahasa Indonesia " was produced by machine.Subtitle "Asụsụ Igbo " was produced by machine.Textun"Íslenska" var framkvæmt vélrænt.Sottotitoli "Italiano" sono stati generati automaticamente.Subtitle "日本語" was produced by machine.Subtitle "Basa Jawa" was produced by machine.Subtitle "ქართული" was produced by machine.Subtitle "қазақ тілі " was produced by machine.Subtitle "ភាសាខ្មែរ" was produced by machine.Subtitle "ಕನ್ನಡ" was produced by machine.Subtitle "한국어" was produced by machine.Subtitle "कोंकणी語" was produced by machine.Subtitle "کوردی" was produced by machine.Subtitle "Кыргызча" was produced by machine.Subtitle " lingua latina" was produced by machine.Subtitle "Lëtzebuergesch" was produced by machine.Subtitle "Lingala" was produced by machine.Subtitle "ພາສາ" was produced by machine.Subtitle "Lietuvių" was produced by machine.Subtitle "Latviešu" was produced by machine.Subtitle "fiteny malagasy" was produced by machine.Subtitle "te reo Māori" was produced by machine.Subtitle "македонски јазик" was produced by machine.Subtitle "malayāḷaṁ" was produced by machine.Subtitle "မြန်မာစာ " was produced by machine.Subtitle "Монгол хэл" was produced by machine.Subtitle "मराठी" was produced by machine.Subtitle "Bahasa Malaysia" was produced by machine.Subtitle "Malti" was produced by machine.Subtitle "ဗမာစာ " was produced by machine.Subtitle "नेपाली" was produced by machine.Subtitle "Nederlands" was produced by machine.Subtitle "Norsk" was produced by machine.Subtitle "chiCheŵa" was produced by machine.Subtitle "ਪੰਜਾਬੀ" was produced by machine.Subtitle "Polska" was produced by machine.Subtitle "پښتو" was produced by machine.Subtitle "Português" was produced by machine.Subtitle "Română" was produced by machine.Subtitle "Язык жестов (Русский)" was produced by machine.Субтитры "Pусский" были созданы машиной.Subtitle "Kinyarwanda" was produced by machine.Subtitle "सिन्धी" was produced by machine.Subtitle "Deutschschweizer Gebärdensprache" was produced by machine.Subtitle "සිංහල" was produced by machine.Subtitle "Slovensky" was produced by machine.Subtitle "Slovenski" was produced by machine.Subtitle "gagana fa'a Samoa" was produced by machine.Subtitle "chiShona" was produced by machine.Subtitle "Soomaaliga" was produced by machine.Subtitle "Shqip" was produced by machine.Subtitle "србски" was produced by machine.Subtitle "Sesotho" was produced by machine.Subtitle "Basa Sunda" was produced by machine.Undertext "Svenska" är maskinell skapad.Subtitle "Kiswahili" was produced by machine.Subtitle "தமிழ்" was produced by machine.Subtitle "తెలుగు" was produced by machine.Subtitle "Тоҷикй" was produced by machine.Subtitle "ภาษาไทย" was produced by machine.Subtitle "ትግርኛ" was produced by machine.Subtitle "Tagalog" was produced by machine.Subtitle "Türkçe" was produced by machine.Subtitle "татар теле" was produced by machine.Subtitle "Українська " was produced by machine.Subtitle "اردو" was produced by machine.Subtitle "Oʻzbek" was produced by machine.Subtitle "Tiếng Việt" was produced by machine.Subtitle "Serbšćina" was produced by machine.Subtitle "isiXhosa" was produced by machine.Subtitle "ייִדיש" was produced by machine.Subtitle "Yorùbá" was produced by machine.Subtitle "中文" was produced by machine.Subtitle "isiZulu" was produced by machine.
kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV не носи отговорност за некачествен превод.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV nenese žádnou odpovědnost za chybné překlady.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV übernimmt keine Haftung für mangelhafte Übersetzung.kla.TV accepts no liability for inadequate translationkla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV no se hace responsable de traducciones incorrectas.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV n'assume aucune responsabilité en cas de mauvaise traduction.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV nem vállal felelősséget a hibás fordításértkla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV tekur enga ábyrgð á áræðanleika þýðingarinnarKla.TV non si assume alcuna responsabilità per traduzioni lacunose e/o errate.Kla.TV は、不適切な翻訳に対して一切の責任を負いません。kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV не несет ответственности за некачественный перевод.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.Kla.TV tar inget ansvar för felaktiga översättningar.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.
BioNTech: Covid-19-premonition, -pre-financing and -crisis profit
The pharmaceutical company BioNTech made a sky rocketing rise in the sector in 2021 and its name is known all over the world. While the company still generated a loss of 181 million euro in 2019, a profit of at least nine billion was expected for 2021. Wouldn’t it be interesting to investigate more closely their modus operandi for success? Who wouldn’t want to rise like an asteroid?
[continue reading]
The pharmaceutical company BioNTech has made a sky rocketing rise in the sector in 2021 and its name is known all over the world.
Although the company lost 181 million euro in 2019,
a nine billion profit at least was expected for 2021.
Wouldn’t it be interesting to take a closer look at their modus operandi? Who wouldn’t want to rise like an asteroid?
The indication „COVID-19“ can be found under the product name „BNT162“ in BioNTech 2019 annual report which can be viewed publicly. This means that the vaccine to treat COVID-19 had to be ready as early as 2017, or by the end of 2018 at the latest. Because at the time of the annual report, the pre-clinical trial and even half of the phase 1 trial had already been fully completed.
Consequently, a business consultant asked BioNTech management:
“How was it possible for your company to develop a therapeutic that had completed preclinical trial by the end of 2019, whereas the virus
emerged just before December 2019?“
She never got an answer.
– Later CEO Türeci reluctantly admitted to the press that she
had been informed beforehand.
If BioNTech was already researching a vaccine for a disease that did not yet exist, could it be that the pandemic was planned for the long term?!
It is worth taking a closer look here. Where did the anticipation come from?
The World Health Summit (WHS) takes place every year in Berlin. In October 2018 Angela Merkel, Bill Gates, Norway’s Prime Minister, WHO Director-General, and the previously widely unknown and financially unsuccessful BioNTech entrepreneur Uğur Şahin met there, among others.
In August 2018, BioNTech signed a contract with Pfizer to develop mRNA-based vaccines to prevent influenza.
Pfizer invested 305 million US dollars in 2018, at a time when BioNTech was still not successful.
The Bill & Melinda Gates Foundation is the main funder of the UK Medicines and Healthcare products Regulatory Agency (MHRA).
In September 2019, shortly before the outbreak of the Covid-19-pandemic, this foundation bought BioNTech shares worth 55 million dollars.
Likewise the European Investment Bank (EIB) pledged 50 million euros to BioNTech.
“The only vaccine that, if everything goes perfectly, could get emergency use approval by the end of October (2020), would be Pfizer”,
Bill Gates stated at the time.
Interestingly enough, the Gates-funded MHRA extended the emergency use authorization of the Pfizer/BioNTech mRNA vaccine in the United Kingdom, so that it could be administered from June 4th, 2021 onwards to children aged 12 to 15 years.
So who is still surprised about the spectacular rise of BioNTech?
Before the pandemic, in 2019, the year with the highest losses to date, BioNTech increased the salaries of the executive board and the supervisory board members, in some cases by almost 1,000 %.
Expressed in numbers: the previous annual salary of CEO Şahin
was increased from 653,000 € to 7,000,064 million €.
The investment of these financiers in a company that had been heavily indebted for years, as well as the unbelievable salary increase, suggest that those involved knew that billions in profits were in sight.
This is one more piece of the puzzle that exposes the pandemic declared in March 2020 as plandemic, in which Bill Gates is a key figure.
Mind you: a plandemic means a pre-planned, artificially triggered crisis from which planners and investors earn a fortune throughout its course.
At the expense of the general public, of course.
Wouldn’t the call for “Money back!” be the appropriate response here?
And shouldn’t crises profits, in other words, making a fortune out of crises, be banned as a matter of principle in order to stop such criminal business models dead in their tracks?
19.05.2022 | www.kla.tv/22536
The pharmaceutical company BioNTech has made a sky rocketing rise in the sector in 2021 and its name is known all over the world. Although the company lost 181 million euro in 2019, a nine billion profit at least was expected for 2021. Wouldn’t it be interesting to take a closer look at their modus operandi? Who wouldn’t want to rise like an asteroid? The indication „COVID-19“ can be found under the product name „BNT162“ in BioNTech 2019 annual report which can be viewed publicly. This means that the vaccine to treat COVID-19 had to be ready as early as 2017, or by the end of 2018 at the latest. Because at the time of the annual report, the pre-clinical trial and even half of the phase 1 trial had already been fully completed. Consequently, a business consultant asked BioNTech management: “How was it possible for your company to develop a therapeutic that had completed preclinical trial by the end of 2019, whereas the virus emerged just before December 2019?“ She never got an answer. – Later CEO Türeci reluctantly admitted to the press that she had been informed beforehand. If BioNTech was already researching a vaccine for a disease that did not yet exist, could it be that the pandemic was planned for the long term?! It is worth taking a closer look here. Where did the anticipation come from? The World Health Summit (WHS) takes place every year in Berlin. In October 2018 Angela Merkel, Bill Gates, Norway’s Prime Minister, WHO Director-General, and the previously widely unknown and financially unsuccessful BioNTech entrepreneur Uğur Şahin met there, among others. In August 2018, BioNTech signed a contract with Pfizer to develop mRNA-based vaccines to prevent influenza. Pfizer invested 305 million US dollars in 2018, at a time when BioNTech was still not successful. The Bill & Melinda Gates Foundation is the main funder of the UK Medicines and Healthcare products Regulatory Agency (MHRA). In September 2019, shortly before the outbreak of the Covid-19-pandemic, this foundation bought BioNTech shares worth 55 million dollars. Likewise the European Investment Bank (EIB) pledged 50 million euros to BioNTech. “The only vaccine that, if everything goes perfectly, could get emergency use approval by the end of October (2020), would be Pfizer”, Bill Gates stated at the time. Interestingly enough, the Gates-funded MHRA extended the emergency use authorization of the Pfizer/BioNTech mRNA vaccine in the United Kingdom, so that it could be administered from June 4th, 2021 onwards to children aged 12 to 15 years. So who is still surprised about the spectacular rise of BioNTech? Before the pandemic, in 2019, the year with the highest losses to date, BioNTech increased the salaries of the executive board and the supervisory board members, in some cases by almost 1,000 %. Expressed in numbers: the previous annual salary of CEO Şahin was increased from 653,000 € to 7,000,064 million €. The investment of these financiers in a company that had been heavily indebted for years, as well as the unbelievable salary increase, suggest that those involved knew that billions in profits were in sight. This is one more piece of the puzzle that exposes the pandemic declared in March 2020 as plandemic, in which Bill Gates is a key figure. Mind you: a plandemic means a pre-planned, artificially triggered crisis from which planners and investors earn a fortune throughout its course. At the expense of the general public, of course. Wouldn’t the call for “Money back!” be the appropriate response here? And shouldn’t crises profits, in other words, making a fortune out of crises, be banned as a matter of principle in order to stop such criminal business models dead in their tracks?
from bri; ew; mbo; nis; hm
Pandemic Prior Knowledge at BioNTech https://bit.ly/3rRgdvG
https://bit.ly/3sO5mSf
Pandemic drivers meeting as early as 2018, with BioNTech https://report24.news/merkel-gates-sahin-dubioses-treffen-der-pandemie-treiber-schon-2018/
Bill Gates - financier of MHRA and BioNTech https://queged.wordpress.com/2021/08/12/bill-gates-ist-der-wichtigste-geldgeber-der-mhra-und-besitzt-grose-anteile-an-pfizer-und-biontech-ist-es-da-ein-wunder-dass-die-mhra-den-impfstoff-fur-kinder-zugelassen-hat/